• Esperion Therapeutics (NASDAQ:ESPR) Given Buy Rating at Needham & Company LLC

    Source: Buzz FX / 14 Dec 2024 13:46:10   America/New_York


    Esperion Therapeutics (NASDAQ:ESPR) Given Buy Rating at Needham & Company LLC Written by MarketBeat December 14, 2024 Share Link copied to clipboard. Esperion Therapeutics ( NASDAQ:ESPR - Get Free Report ) 's stock had its "buy" rating reis
    Read more...
Share on,